MedPath

To see the usefulness of attenuation of nerve causing heel pain by using instrument in the management of chronic heel pain

Phase 3
Recruiting
Conditions
Plantar fascial fibromatosis,
Registration Number
CTRI/2019/09/021308
Lead Sponsor
Department of Physical Medicine and Rehabilitation
Brief Summary

Plantar fasciitis remains one of the leading causes of long term disability. Many studies have been conducted on management of pain and improvement in foot function. Therapy in the form of rest, stretching, analgesic agents, physical therapy, arch support, night splints, shoe modifications or steroid injections are the conservative treatments available. Extracorporeal shock wave therapy (ESWT), radiofrequency nerve ablation (RFNA) and platelet rich plasma (PRP) are other options that can be considered for recalcitrant plantar fasciitis. At present there are very limited literature regarding RFNA of medial calcaneal nerve for the treatment of recalcitrant plantar fasciitis. Therefore, the aim of the study is to determine the effectiveness of ultrasound guided radiofrequency nerve ablation in the management of plantar fasciitis. A sample size of 39 patients in each group who are willing to take part in the study will be taken from those plantar fasciitis patients who are attending the OPD of PMR department, RIMS. Outcomes will be measured by using , visual analogue scale ( VAS), ultrasound measurement of plantar fascia thickness and American Orthopedic Foot and Ankle Society (AOFAS) ankle hind-foot score at one, four, twelve and twenty-four weeks post- intervention. Study design will be randomized controlled trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
78
Inclusion Criteria

Patients with plantar fasciitis for 6 months not responding to conservative management.

Exclusion Criteria

Inflammatory arthritis,neurological defects of the foot,coagulopathy,infection,cancer,peripheral vascular, pregnancy, previous surgery on the plantar fascia or heel,previous local steroid injecctions within 3 monthsof the study, distorted anatomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale, American Orthopedic Foot and Ankle Society (AOFAS)Baseline, 4th, 12th and 24th week
Secondary Outcome Measures
NameTimeMethod
Plantar fascia thickness measured by ultrasoundBaseline, 4th, 12th and 24th week

Trial Locations

Locations (1)

Regional Institute of Medical Sciences, Imphal

🇮🇳

West, MANIPUR, India

Regional Institute of Medical Sciences, Imphal
🇮🇳West, MANIPUR, India
Dr Moirangthem Janet
Principal investigator
8014932808
vivienne2811@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.